Literature DB >> 31649416

Estimation of Multi-state Models with Missing Covariate Values Based on Observed Data Likelihood.

Wenjie Lou1,2, Erin L Abner2,3, Lijie Wan1,2, David W Fardo4,2, Richard Lipton5, Mindy Katz5, Richard J Kryscio1,4,2.   

Abstract

Continuous-time multi-state models are commonly used to study diseases with multiple stages. Potential risk factors associated with the disease are added to the transition intensities of the model as covariates, but missing covariate measurements arise frequently in practice. We propose a likelihood-based method that deals efficiently with a missing covariate in these models. Our simulation study showed that the method performs well for both 'missing completely at random' and 'missing at random' mechanisms. We also applied our method to a real dataset, the Einstein Aging Study.

Entities:  

Keywords:  Longitudinal data; MAR; MCAR; missing covariate; multi-state model

Year:  2018        PMID: 31649416      PMCID: PMC6812530          DOI: 10.1080/03610926.2018.1520884

Source DB:  PubMed          Journal:  Commun Stat Theory Methods        ISSN: 0361-0926            Impact factor:   0.863


  16 in total

Review 1.  Multi-state models: a review.

Authors:  P Hougaard
Journal:  Lifetime Data Anal       Date:  1999-09       Impact factor: 1.588

2.  Multi-state models for bleeding episodes and mortality in liver cirrhosis.

Authors:  P K Andersen; S Esbjerg; T I Sorensen
Journal:  Stat Med       Date:  2000-02-29       Impact factor: 2.373

3.  Multi-state models in epidemiology.

Authors:  D Commenges
Journal:  Lifetime Data Anal       Date:  1999-12       Impact factor: 1.588

4.  SAS macro program for non-homogeneous Markov process in modeling multi-state disease progression.

Authors:  Wu Hui-Min; Yen Ming-Fang; Tony Hsiu-Hsi Chen
Journal:  Comput Methods Programs Biomed       Date:  2004-08       Impact factor: 5.428

5.  Efficient evaluation of treatment effects in the presence of missing covariate values.

Authors:  M Schemper; T L Smith
Journal:  Stat Med       Date:  1990-07       Impact factor: 2.373

6.  Incidence of dementia and cognitive impairment, not dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Ryan J McCammon; Gwenith G Fisher; Guy G Potter; James R Burke; David C Steffens; Norman L Foster; Bruno Giordani; Frederick W Unverzagt; Kathleen A Welsh-Bohmer; Steven G Heeringa; David R Weir; Robert B Wallace
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

7.  Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study.

Authors:  Mindy J Katz; Richard B Lipton; Charles B Hall; Molly E Zimmerman; Amy E Sanders; Joe Verghese; Dennis W Dickson; Carol A Derby
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

8.  Multi-stage transitional models with random effects and their application to the Einstein aging study.

Authors:  Changhong Song; Lynn Kuo; Carol A Derby; Richard B Lipton; Charles B Hall
Journal:  Biom J       Date:  2011-10-21       Impact factor: 2.207

9.  Incidence and mortality of Alzheimer's disease or dementia using an illness-death model.

Authors:  D Commenges; P Joly; L Letenneur; J F Dartigues
Journal:  Stat Med       Date:  2004-01-30       Impact factor: 2.373

10.  Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia.

Authors:  Richard J Kryscio; Erin L Abner; Yushun Lin; Gregory E Cooper; David W Fardo; Gregory A Jicha; Peter T Nelson; Charles D Smith; Linda J Van Eldik; Lijie Wan; Frederick A Schmitt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.